PHARMANIAGA |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.35 MYR | 0.00% |
|
+2.94% | -9.09% |
| Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
| Mar. 27 | Pharmaniaga Berhad Appoints Tuan Drs. Imam Fathorrahman as Independent and Non Executive Member of Audit Committee | CI |
Evolution of the average Target Price on Pharmaniaga
Price target over the last 5 years
History of analyst recommendation changes
447dfb4f7c887.TPGU3xIN7cyi1Kc2M7O4_nsOHnAm0RGBnzlckGfc3N4.HJ3BnXA4t6jBpsAOQfXrqRQ2bgluun_N3FsQxx20ro4nluSQaEGe_OydyA~38e6228ff292764176c5dab0440e2c69
Analysts' Consensus
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.35
MYR
Average target price
0.31
MYR
Spread / Average Target
-11.43%
High Price Target
0.31
MYR
Spread / Highest target
-11.43%
Low Price Target
0.31
MYR
Spread / Lowest Target
-11.43%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHARMA Stock
- Consensus Pharmaniaga
